While CAR expression was not correlated with disease progression (data not shown), CD46 expression was negatively correlated with tumor stage (p = 0.017), tumor grade (p = 0.012), and European organisation for research and treatment of cancer (EORTC) risk group (p = 0.042). This evidence concerns the gene CD46 and neoplasm.